PhysIQ™s proprietary personalized physiology analytics (PPA) technology learns the unique interplay between continuous physiological signals such as heart rate, respiration rate, oxymetry, blood pressure and any number of others, creating a dynamic multivariate baseline for each patient.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 07/25/14 | $4,600,000 |
LionBird | undisclosed | |
| 07/25/17 | $8,000,000 | Series B |
4490 Ventures LionBird Quark Venture | undisclosed |
